Geode Capital Management LLC Has $124.50 Million Holdings in Doximity, Inc. (NASDAQ:DOCS)

Geode Capital Management LLC lifted its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 19.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,856,984 shares of the company's stock after buying an additional 472,565 shares during the quarter. Geode Capital Management LLC owned about 1.54% of Doximity worth $124,503,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its position in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after acquiring an additional 603 shares in the last quarter. Blue Trust Inc. increased its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock worth $37,000 after buying an additional 1,193 shares during the last quarter. Quarry LP raised its holdings in Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company's stock valued at $45,000 after buying an additional 131,253 shares in the last quarter. Morse Asset Management Inc bought a new stake in shares of Doximity during the 3rd quarter worth about $46,000. Finally, First Horizon Advisors Inc. boosted its stake in shares of Doximity by 80.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company's stock worth $48,000 after acquiring an additional 760 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on DOCS. Robert W. Baird upped their target price on Doximity from $41.00 to $45.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 17th. Canaccord Genuity Group downgraded shares of Doximity from a "buy" rating to a "hold" rating and lifted their target price for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. Raymond James restated an "outperform" rating and set a $65.00 price target (up from $37.00) on shares of Doximity in a report on Friday, November 8th. JPMorgan Chase & Co. lifted their price objective on Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a research note on Thursday, November 21st. Finally, KeyCorp upgraded Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 target price for the company in a research note on Friday, November 8th. Twelve research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $52.44.

Doximity Stock Performance

NASDAQ DOCS traded down $0.51 during trading on Wednesday, reaching $52.19. 2,269,827 shares of the company traded hands, compared to its average volume of 1,750,335. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The stock's 50 day moving average price is $48.41 and its two-hundred day moving average price is $38.36. The company has a market cap of $9.74 billion, a price-to-earnings ratio of 59.99, a P/E/G ratio of 4.16 and a beta of 1.40.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.